BNTC Benitec Biopharma Inc
6,568
$8.55
$0.47
(5.21%)
| Watchers | 6,568 |
| 52-Wk Low | $1.86 |
| 52-Wk High | $10.70 |
| Market Cap | $24.58M |
| Volume | 88,289.00 |
| 52-Wk High | $10.70 |
| 52-Wk Low | $1.86 |
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Down 68.3% in MarchTicker Report • 2 months ago
Benitec Biopharma Inc. (NASDAQ:BNTC Get Free Report) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 5,100 shares, a...
Share to Feed
Benitec Biopharma (NASDAQ:BNTC Free Report) had its price objective hoisted by JMP Securities from $8.00 to $10.00 in a research report report published on Thursday morning, Benzinga reports...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
-First Subject Dosed with BB-301 in Phase 1b/2a Clinical Treatment Study (NCT06185673) in November 2023- -Data Safety Monitoring Board Review for First Subject Completed After Day 28 Study Visit...
Benitec Biopharma Inc. (NASDAQ:BNTC Get Free Report) saw a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 6,200 shares...